Daily Ammoxetine at 40, 60 mg Outperforms Placebo for MDD in Phase 2 Trial - HCPLive

Submitted by Anonymous (not verified) on Tue, 09/30/2025 - 12:06

Daily Ammoxetine at 40, 60 mg Outperforms Placebo for MDD in Phase 2 Trial  HCPLive